Week 9 HW: Cell-Free Systems

Part 1: General and Lecturer-Specific Questions

General homework questions

1. Explain the main advantages of cell-free protein synthesis over traditional in vivo methods, specifically in terms of flexibility and control over experimental variables. Name at least two cases where cell-free expression is more beneficial than cell production.

The fundamental advantage of cell-free protein synthesis (CFPS) lies in the removal of the cellular membrane, which effectively transforms a “black box” biological process into an open, accessible engineering platform. By eliminating the cell wall, researchers gain unprecedented flexibility and direct control over experimental variables; the reaction environment can be precisely manipulated by adding non-natural amino acids, specific chaperones, or tailored energy sources without the constraints of cellular transport or homeostasis. Furthermore, CFPS decouples protein production from host viability, allowing for the synthesis of highly cytotoxic proteins that would otherwise trigger cell death and halt production in traditional in vivo systems.Beyond throughput, the “open” nature of the system significantly enhances real-time monitoring and process optimization. Unlike the opaque interior of a living E. coli cell, a cell-free reactor allows for millisecond-scale sampling and mid-process adjustments of critical concentrations—such as magnesium levels or pH—to maximize yields. Perhaps most importantly for rapid prototyping, CFPS enables a drastically accelerated iteration cycle. By bypassing time-consuming steps like transformation, plating, and overnight culturing, researchers can transition from a linear DNA template (such as a PCR product) to a functional protein in just a few hours, representing a paradigm shift in the speed of biological design.

• Case A: Production of Cytotoxic Proteins Many useful proteins, such as antimicrobial peptides (AMPs) or certain lytic enzymes (like the ones you might use in Bioplastix), kill the host cell as soon as they are expressed. CFPS allows you to synthesize these “suicide” proteins because the system lacks the physiological targets that the toxins would otherwise destroy.

• Case B: Incorporation of Non-Standard Amino Acids (nsAAs) If you want to create a protein with expanded chemical properties (e.g., for site-specific labeling, “click” chemistry, or enhanced stability), CFPS is superior. In a cell, it is extremely difficult to “force” the machinery to use a synthetic amino acid without interfering with the cell’s own survival. In a cell-free extract, you can simply “starve” the reaction of a natural amino acid and flood it with the synthetic version.

2. Describe the main components of a cell-free expression system and explain the role of each component.

• The Biological Extract (The Machinery): usually obtained by lysing cells (such as E. coli, wheat germ, or rabbit reticulocytes) and removing the cell wall and genomic DNA. It provides the Ribosomes for translation, RNA Polymerase for transcription, and various tRNAs, aminoacyl-tRNA synthetases, and initiation/elongation factors. Without the extract, there is no hardware to read the genetic code.
• The DNA Template (The Instructions): Unlike in vivo systems that require circular plasmids, cell-free systems can often use linear DNA (like PCR products). It provides the genetic sequence of the protein of interest. It must contain specific regulatory elements that the extract’s machinery can recognize, such as a T7 or endogenous promoter, a Ribosome Binding Site (RBS), and a terminator.
• Energy Regeneration System (The Fuel): Protein synthesis is energetically expensive. Since the cell’s natural mitochondria or metabolic pathways are no longer intact, we must provide an external energy source. It consists of NTPs (ATP, GTP, UTP, CTP) which act as the direct building blocks for mRNA and the energy source for the ribosome. It also includes an energy-rich secondary substrate (like phosphoenolpyruvate (PEP) or creatine phosphate) and a corresponding kinase to “recharge” the ATP as it is consumed.
• Small Molecules and Buffers (The Environment): A precise chemical environment is required to keep the enzymes stable and active. Amino Acids: The raw building blocks used to assemble the protein chain. Magnesium and Potassium salts: Critical cofactors for ribosome assembly and stability. Buffers (e.g., HEPES): To maintain a stable pH, as the metabolic byproducts of the reaction can quickly acidify the mixture.

3. Why is energy provision regeneration critical in cell-free systems? Describe a method you could use to ensure continuous ATP supply in your cell-free experiment.

Protein synthesis requires a massive amount of energy at every stage. For every single amino acid added to a polypeptide chain, four high-energy phosphate bonds are consumed: two during the “charging” of the tRNA with an amino acid and two during the translation elongation steps (GTP hydrolysis).In a static cell-free batch, the initial supply of ATP would be depleted almost instantly. Furthermore, the accumulation of Inorganic Phosphate —a byproduct of ATP hydrolysis—can inhibit the reaction by chelating magnesium ions, which are essential for ribosome stability. Therefore, a regeneration system is critical not just to keep the “fuel tank” full, but to maintain a chemical environment that isn’t poisoned by its own waste.

To ensure a steady supply of ATP in your HTGAA experiments, two strategies are:

• The Creatine Phosphate / Creatine Kinase (CP/CK) System. This is the most common “plug-and-play” method for cell-free experiments. You add Creatine Phosphate (the high-energy substrate) and the enzyme Creatine Kinase to the mixture. Every time an ATP molecule is used and becomes ADP, the Creatine Kinase transfers a phosphate group from the Creatine Phosphate directly back to the ADP, “recharging” it into ATP instantly. It is highly efficient and maintains a very high [ATP]/[ADP] ratio, which is vital for high-yield protein production.

• PURE System or Secondary Carbon Sources. If you are using an E. coli extract, you can utilize the cell’s own residual glycolytic enzymes. You provide a secondary energy source like Phosphoenolpyruvate (PEP) or Glucose-6-Phosphate. The enzymes already present in the extract (like pyruvate kinase) process these substrates to regenerate ATP. The “Continuous” Approach: For very long experiments, you can use a Dialysis System (Continuous Exchange Cell-Free - CECF). The reaction happens inside a dialysis membrane submerged in a large reservoir of buffer, energy substrates, and nucleotides. Fresh fuel diffuses in, and inhibitory byproducts like inorganic phosphate diffuse out, allowing the reaction to run for days.

4. Compare prokaryotic versus eukaryotic cell-free expression systems. Choose a protein to produce in each system and explain why.

The choice between prokaryotic and eukaryotic cell-free expression systems is primarily dictated by the complexity of the protein and the requirement for post-translational modifications (PTMs). Prokaryotic systems, typically based on E. coli S30 extracts, are the “workhorses” of the field due to their high protein yields (often reaching mg/mL levels), low cost, and rapid synthesis rates. They utilize 70S ribosomes and simpler energetic pathways but lack the machinery for complex folding or PTMs like glycosylation. In contrast, eukaryotic systems—such as Wheat Germ Extract (WGE) or Rabbit Reticulocyte Lysate (RRL)—employ 80S ribosomes and offer a more sophisticated folding environment. While they generally produce lower total yields and are more expensive to prepare, they are indispensable for synthesizing large, multi-domain eukaryotic proteins that require authentic folding or specific modifications like disulfide bond formation, phosphorylation, or lipidation.

70S and 80S Ribosomes: These are the molecular machines responsible for protein synthesis. The “S” (Svedberg unit) indicates their size and sedimentation rate during centrifugation. 70S Ribosomes: Found in prokaryotes (bacteria) and organelles like mitochondria. They are smaller and simpler in structure. 80S Ribosomes: Found in eukaryotes (animals, plants, fungi, and humans). They are larger, more complex, and capable of more sophisticated regulation of translation.

PTMs are chemical changes made to a protein after it has been synthesized by the ribosome. These modifications are essential for the protein to become biologically functional. Examples: Glycosylation (adding sugars), phosphorylation (adding phosphate groups), and disulfide bond formation. Importance: While bacteria are efficient at making simple proteins, they lack the machinery for most complex eukaryotic PTMs, which is why human proteins often require eukaryotic expression systems to function correctly.

• For a prokaryotic system (E. coli), an ideal protein to produce would be Green Fluorescent Protein (GFP) or a bacterial enzyme like Pyruvate Kinase. GFP is a robust, relatively small protein that folds efficiently in the bacterial cytoplasm without needing PTMs. Using an E. coli cell-free extract allows for massive production in just a few hours, making it perfect for high-throughput screening of genetic circuits or biosensors where speed and quantity are prioritized over structural complexity.

• For a eukaryotic system (such as Rabbit Reticulocyte Lysate), a strategic choice would be a human therapeutic protein like Erythropoietin (EPO) or a complex Single-Chain Variable Fragment (scFv) antibody. EPO requires extensive and specific glycosylation to be biologically active and stable in the human body—a process that E. coli machinery cannot perform. By using a mammalian-derived cell-free system (often supplemented with microsomal membranes), researchers can ensure the protein is correctly glycosylated and folded with the necessary disulfide bridges, providing a functional product that closely mimics its natural human counterpart.

5. How would you design a cell-free experiment to optimize the expression of a membrane protein? Discuss the challenges and how you would address them in your setup.

Use a cell-free system supplemented with liposomes or nanodiscs (synthetic lipid bilayers). This allows the membrane protein to integrate into a stable environment as it is synthesized.

Challenge 1: Hydrophobicity and Aggregation. Membrane proteins often precipitate in aqueous extracts. Solution: Add detergents (at sub-CMC levels) or chaperones to maintain solubility.

Challenge 2: Lack of Energy/Substrates. Solution: Use a Continuous-Exchange (CECF) system to provide a steady supply of energy and remove inhibitory byproducts, ensuring longer reaction times for difficult folding.

6. Imagine you observe a low yield of your target protein in a cell-free system. Describe three possible reasons for this and suggest a troubleshooting strategy for each.

• DNA Template Quality: Verify DNA purity (A260/280 ratio) and ensure the promoter/RBS sequences are optimized for the specific extract used.
• Resource Exhaustion: Increase the concentration of the energy regeneration system (e.g., Creatine Phosphate) or optimize the Magnesiu concentration.
• Protein Degradation: Add Protease Inhibitors to the extract or use a specialized strain (like BL21 E. coli) that is deficient in endogenous nucleases and proteases.

Homework question from Kate Adamala

Design of a Synthetic Minimal Sentinel Cell for Autolysis Testing

• Function and Operation: A “Self-Destructing Sentinel” that replicates the dual-sensing logic. It is designed to sequester a payload and release it only when two specific environmental conditions are met: phosphate starvation and a temperature shift. Input: 1. Low concentration of inorganic phosphate. 2. Thermal shift (e.g., transition from 30°C to 37°C).Output: Expression of the Lambda phage lysis cassette (SRRz) leading to membrane rupture and release of internal contents.
• Realization and Feasibility: Cell-free Tx/Tl alone: Without encapsulation, the “lysis” has no physical meaning. You could produce the proteins, but you wouldn’t be able to measure the structural failure or the release kinetics that your industrial process needs. Genetically modified natural cell: While this is an end goal for E. coli, testing it first in a minimal cell is safer. In a natural cell, phosphate starvation triggers many “survival” pathways that might interfere with your promoter’s strength. The minimal cell provides a “clean” signal-to-noise ratio.
• Components and Encapsulation: Membrane: A lipid bilayer composed of POPC and DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine). DOPE adds curvature tension, making the membrane more sensitive to the “holes” created by the holins (S protein) of the SRRz cassette. Internal Content: Extract: E. coli S30 cell-free extract (Prokaryotic system). Machinery: Endogenous E. coli RNA polymerase and ribosomes. Small Molecules: NTPs, Amino Acids, and a buffer with initially high phosphate that will be “consumed” or diluted to trigger the circuit.
• Communication and System Origin: Bacterial (E. coli). The circuit uses the pPhoA promoter, which is native to E. coli. Using a bacterial cell-free extract ensures that the transcription factors (like PhoB) required for the pPhoA promoter to work are present. To simulate phosphate starvation, we can use Alpha-hemolysin pores. These allow phosphate to diffuse out of the minimal cell into a phosphate-free external buffer, triggering the internal sensor.
• Experimental Details: The minimal cell will encapsulate:Lipids: POPC and DOPE. Genes (The Circuit): pPhoA Promoter: Driving the first stage of the cascade. It responds to the lack of phosphate.Temperature-Sensitive Riboswitch: Placed upstream of the SRRz sequence. Even if pPhoA is active, the mRNA won’t be translated unless the temperature reaches the threshold (e.g., 37°C), which unfolds the riboswitch. SRRz Cassette: The “actuator” consisting of S (holin), R (endolysin), and Rz (spanin).
• Measuring Function: We will validate the design using: Phase-Contrast Microscopy to visually observe the “bursting” of the vesicles when phosphate is depleted and temperature is raised. Fluorescence Release Assay: We will co-encapsulate a large fluorescent protein (like mCherry). We will measure the increase in external fluorescence over time. Success Metric: If fluorescence remains internal at 30°C regardless of phosphate levels, but releases at 37°C under low phosphate, the logic is proven.

Homework question from Peter Nguyen

• Proposal Pitch: The “Sentinel Bio-Textile”

• One-sentence summary pitch: A smart, biodegradable textile infused with freeze-dried cell-free systems that acts as a “living” safety suit, detecting environmental pathogens and neutralizing them through the inducible secretion of antimicrobial peptides.

• How will the idea work? The textile fibers are embedded with a freeze-dried E. coli cell-free extract containing the genetic instructions for a pathogen-sensing riboswitch and an actuator gene. When a specific pathogen (or a chemical marker of contamination) is detected, the dehydrated machinery is activated by ambient moisture or sweat, triggering the transcription and translation of the circuit. The system then produces and secretes Antimicrobial Peptides (AMPs) or lytic enzymes directly onto the fabric surface. This creates a localized, on-demand decontamination zone without the need for living, genetically modified organisms to survive on the wearer’s skin.

• What societal challenge or market need will this address? This addresses the growing need for advanced Personal Protective Equipment (PPE) in healthcare and industrial settings, where traditional fabrics only provide a passive physical barrier. Currently, PPE often becomes a vector for cross-contamination; a bio-active textile that actively “cleans” itself or alerts the user to invisible threats would significantly reduce the spread of hospital-acquired infections and enhance worker safety in bio-hazardous environments.

• Addressing limitations (Activation, Stability, One-time use) Activation: The freeze-dried components remain dormant and stable at room temperature until they come into contact with a specific trigger, such as a localized application of water or a “developer” spray. Stability: By using lyoprotectants (like sucrose or trehalose) during the freeze-drying process, the enzymatic machinery is shielded from thermal degradation, allowing for a long shelf-life in standard warehouse conditions. One-time use: While the reaction is currently a one-time “pulse,” we envision the textile as a modular patch system. Once the “biological fuse” has been spent, the functionalized patch can be swapped out or discarded, taking advantage of the biodegradable nature of the underlying Bioplastix material.

Homework question from Ally Huang